TerminatedNCT02418754
Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)
PHASE2 · 505 planned enrolment
- Countries listed
- 2
- Registry update
- October 26, 2020
immortal.lifeTrial registrations containing the exact intervention label REGN2176-3.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE2 · 505 planned enrolment
PHASE1 · 12 planned enrolment